The concern from the FDA comes after the dye was found to cause cancer in rats during testing.
AND EARLIER THIS WEEK, THE FDA ANNOUNCED THE BAN OF RED DYE NUMBER THREE. THE CONTROVERSIAL INGREDIENT OFTEN FOUND IN DRINKS, CANDY AND CEREAL. I’M JOINED NOW BY DOCTOR TARA KESTER, AND INTEGRATED ...
The Centers for Medicare and Medicaid Services (CMS) identified 15 drugs it has selected for price negotiations with drug ...
AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
Temple pulmonologist Dr. Jamie Garfield says the proposed regulation is an effective harm reduction strategy, but suggests it ...
On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...
The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.
The U.S. Food and Drug Administration has sent a warning letter to Marlborough, Mass.-based medical technology company ...
VERIFY answers four questions about the common food additive red dye No. 3, including what products contain it and if the FDA ...
Virginia G. Kaklamani, MD, DSc, discusses findings from the phase 3 TROPION-Breast01 trial of datopotamab deruxtecan.
Scientists have made 'exciting,' patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds ...